Development and preclinical validation of selective dapk1 inhibitor drugs with potent antitumor action
UGR001 / A-04 / PI
Year of the call
2016
Execution date
01/01/2017 - 31/12/2018
IP
IGNACIO J MOLINA PINEDA DE LAS INFANTAS
UGR001 / A-04 / PI
2016
01/01/2017 - 31/12/2018
IGNACIO J MOLINA PINEDA DE LAS INFANTAS